XENE: Total Utang marang Modal Xenon

Logo perusahaan publik Xenon (XENE)

Xenon Pharmaceuticals specializes in developing innovative therapies for epilepsy. This price chart, which assists in the basic asset valuation, demonstrates the impact of partnerships with global giants on project development, while the debt load stands at 0.01. The company is implementing AI for digital molecular modeling, although final verification requires medical professional involvement. High capital expenditure and uncertainty regarding the outcome of final tests create significant financial risks.

XENE - Total Utang marang Modal Xenon ing rentang 04.07.2022 - 31.10.2026

Rincian metrik lan analitis perusahaan Xenon Corp (XENE)

- rega lan prakiraan konsensus rega:
Bagan rega Xenon|XENE - Prakiraan gabungan firma investasi
- informasi kapitalisasi pasar:
Kapitalisasi pasar Xenon Pharmaceuticals|XENE - Total Nilai Perusahaan
- indikator kapitalisasi buku:
Nilai Akuntansi saben Saham Xenon Pharmaceuticals|XENE - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku xenon-pharma.com|XENE - Nilai Agregat Aset
- indikator beban kredit lan likuiditas emiten:
Utang marang Ekuitas Xenon Pharmaceuticals|XENE - Kewajiban jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Xenon Pharmaceuticals|XENE - Utang agregat perusahaan|Utang-utang marang kapitalisasi buku Xenon Pharmaceuticals|XENE - Utang jangka dawa|Utang jangka cendhak perusahaan Xenon Pharmaceuticals|Likuiditas cepet xenon-pharma.com
- statistik bathi lan rasio pasar:
XENE - Penghasilan resik perusahaan
Analisis umum perusahaan:Xenon, XENE
Barang utama xenon-pharma.com

The debt_total_eq_co ratio measures the extent of a business's reliance on external borrowings relative to its own assets, determining financial stability and insolvency risk. Analyzing the balance between debt and equity allows for the separation of Xenon Pharmaceuticals (XENE) systemic stability from temporary fluctuations, which is critical when raising funds for costly epilepsy drug research amidst fierce competition.

Pesaing Xenon Pharmaceuticals

Utang marang Ekuitas Biogen|Rasio Utang marang Ekuitas NBIX (Neurocrine)|Total Utang marang Modal RGC|AXSM - Utang marang Modal|ACADIA Pharmaceuticals - Rasio Total Utang marang Ekuitas|Total Utang marang Modal vikingtherapeutics.com VKTX|SUPN - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi CPRX (Catalyst Pharma)|Denali Therapeutics Inc (DNLI) - Utang marang Ekuitas|Utang marang Modal Harmony Corp (HRMY)|Rasio Total Utang marang Ekuitas BHVN|Rasio Utang marang Ekuitas AMLX (amylyx.com)|Total Utang marang Modal TRVI|PRAX - Utang marang Modal|Utang marang Ekuitas Anavex Corp AVXL|CBLL: Rasio Utang marang Ekuitas|PRTA - Utang marang Ekuitas|Utang marang Modal Alector, Inc.|Annexon (ANNX) - Utang marang Ekuitas|Rasio Utang marang Ekuitas OMER|Rasio Total Utang marang Ekuitas NGNE|ACIU: Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Voyager Therapeutics (VYGR)|NMRA: Utang Agregat marang Ekuitas|Total Utang marang Modal SCLX (Scilex)|Rasio Kabeh Utang marang Dana Pribadi TVGN|Alpha Cognition Corp - Total Utang marang Modal|CGTX - Total Utang marang Modal|Inhibikase Therapeutics (IKT) - Utang marang Ekuitas|cassavasciences.com - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Assertio Holdings|Rasio Total Utang marang Ekuitas Coya (COYA)|Total Utang marang Modal VTGN|Total Utang marang Modal ovidrx.com (OVID)|Total Utang marang Modal ABOS (Acumen Pharmaceuticals)|CRVO - Rasio Total Utang marang Ekuitas|Alterity Therapeutics Ltd - Total Utang marang Modal|Utang marang Modal Clene Inc.|PEPG (pepgen.com) - Rasio Total Utang marang Ekuitas|Jupiter Neurosciences, Inc. (JUNS) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas RLMD|ANVS (annovisbio.com) - Utang Agregat marang Modal|Total Utang marang Modal GRCE|Koefisien Total Utang marang Modal Firefly Neuroscience, Inc.|Total Utang marang Modal KLTO (Klotho Neurosciences)|NRSN - Rasio Total Utang marang Ekuitas|Reviva Pharmaceuticals - Total Utang marang Modal|MTVA - Total Utang marang Modal|NeurAxis (NRXS) - Utang marang Ekuitas|HSDT (Helius Medical Technologies) - Utang marang Ekuitas|Utang marang Ekuitas Passage Bio Inc.|Neuphoria (NEUP) - Koefisien Total Utang marang Modal|Rasio Total Utang marang Ekuitas NERV (Minerva Neurosciences)|athira.com - Rasio Utang marang Ekuitas|Total Utang marang Modal ADXN (Addex Therapeutics Ltd)|Alzamend Neuro Inc. (ALZN) - Utang marang Modal|CYCN - Utang marang Ekuitas|PTIX (Protagenic Therapeutics) - Rasio Utang marang Ekuitas|KTTA: Total Utang marang Modal|Utang marang Modal Cortigent (CRGT)|Utang marang Ekuitas Avenue Therapeutics, Inc.|Rasio Utang marang Ekuitas BCLI (Brainstorm Cell Therapeutics Inc.)|Total Utang marang Modal CARA|CHRO - Utang marang Modal|Eliem Therapeutics Inc. - Rasio Total Utang marang Ekuitas|Total Utang marang Modal Intra-Cellular Therapies Inc. ITCI|LBPH - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi MRNS (Marinus Pharmaceuticals Inc)|NKGen (NKGN) - Utang marang Ekuitas|Utang marang Modal NeuroBo Pharma (NRBO)|Rasio Total Utang marang Ekuitas SAGE|Rasio Utang marang Ekuitas SNPX (synaptogen.com)|Total Utang marang Modal TRVN|VIGL - Utang marang Modal|Utang marang Ekuitas Anew Medical WENA|CERE: Rasio Utang marang Ekuitas